Escalon Medical Corp. announced unaudited consolidated earnings results for the second quarter and six months ended December 31, 2014. For the second quarter of fiscal 2015, consolidated product revenue increased to $3.7 million from $3.1 million in the year ago period primarily as a result of an increase in sales of the Company's Sonomed Escalon Digital Imaging products, Axis management systems as well as an increase in the sales of the Company's Ultrasound and surgical products. For the quarter ended December 31, 2014, the company reported a net loss of $74,089 and a net loss from continuing operations of $76,748 or $0.01 per basic and diluted share. This compares to a net loss of $108,549 for the second quarter of fiscal 2014 and a net loss from continuing operations of $82,715 or $0.01 per basic and diluted share. Net revenue was $3,699,654 against $3,078,485 a year ago. Loss from operations was $76,774 against $89,306 a year ago.

For the first six months of fiscal 2015, the company reported a net loss of $533,048, or $0.07 per basic and diluted share, and a net loss from continuing operations of $516,944. The net loss from continuing operations was $43,870, and net loss of $95,309 or $0.01 per basic and diluted share, for the first six months of the prior fiscal year. Net revenue was $6,329,974 against $6,208,568 a year ago. Loss from operations was $517,009 against $51,590 a year ago.

The company is continuing to drive improved operational and financial results throughout the rest of fiscal 2015.